血管内治疗:优势管径M2段闭塞在缺血性卒中中的作用
基于MR CLEAN登记研究,比较因M2与M1闭塞行血管内治疗(EVT)的急性缺血性卒中患者的功能结局、技术方面及并发症。结果显示M2与M1闭塞患者的功能结局无显著差异(调整共同比值比1.24;95%CI 0.87-1.73),症状性颅内出血发生率相似(6.6% vs 5.9%;P=0.84)。对M2分支优势的进一步分析显示,再灌注状态与功能结局的关联在各亚组相似,无证据表明优势或非优势M2闭塞患者应常规排除EVT。
要点
- M2与M1闭塞患者EVT后功能结局无显著差异。
- M2与M1闭塞的症状性颅内出血发生率相似。
- 优势或非优势M2闭塞不应常规排除EVT。
核心结论
- M2与M1闭塞患者EVT后的结局和并发症率相似。
- 再灌注状态与功能结局的关联在所有亚组相似,无证据表明优势或非优势M2闭塞应常规排除EVT。
研究设计与样本
- 研究基于MR CLEAN登记研究,该研究为在荷兰16个中心进行的正在进行的观察性研究。
- 共分析244例(24%)M2闭塞和759例(76%)M1闭塞接受EVT的患者。
- 功能结局用90天改良Rankin量表评分测量。
- 对M2分支优势的分析在175例(72%)患者中进行。
主要发现
- M2与M1闭塞患者的功能结局无显著差异(调整共同比值比1.24;95%CI 0.87-1.73)。
- M2与M1闭塞的症状性颅内出血发生率相似(6.6% vs 5.9%;P=0.84)。
- 神经功能恢复可比(平均delta NIHSS:优势M2 -2±10,非优势M2 -5±5,M1 -4±9;P=0.24)。
- 再灌注状态对功能结局的影响在闭塞分支间可比(优势M2共同比值比1.27;95%CI 1.06-1.53;非优势M2共同比值比1.32;95%CI 0.93-1.87;M1共同比值比1.35;95%CI 1.24-1.46)。
临床怎么用
- 对于M2闭塞的急性缺血性卒中患者,EVT的结局和并发症与M1闭塞相似。
- 不应仅因优势或非优势M2闭塞而常规排除EVT。
局限性
- 基于观察性数据且样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- It is unclear whether endovascular treatment (EVT) is beneficial for patients with acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery. We aimed to compare functional outcomes, technical aspects, and complications of EVT between patients with acute ischemic stroke because of M2 and M1 occlusions in clinical practice. Furthermore, outcome and complications after EVT in dominant and nondominant caliber M2 division occlusions were studied. Methods- Data were obtained from the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) which is an ongoing observational study in 16 Dutch centers performing EVT in the Netherlands. Functional outcome was measured with the modified Rankin Scale score at 90 days. Neurological recovery (delta National Institutes of Health Stroke Scale), successful reperfusion rates (extended Thrombolysis in Cerebral Infarction ≥2B), and safety outcomes were also investigated. Associations between occlusion location and outcome were analyzed with ordinal logistic regression models, with adjustment for other prognostic factors. Results- In total, 244 (24%) patients with an M2 and 759 (76%) patients with an M1 occlusion who underwent EVT were analyzed. Functional outcomes were not significantly different between patients with M2 versus M1 occlusions (adjusted common odds ratio, 1.24; 95% CI, 0.87-1.73). Occurrence of symptomatic intracerebral hemorrhage was also similar for M2 and M1 occlusions (6.6% versus 5.9%; P=0.84). Further analysis about dominance of an M2 branch was performed in 175 (72%) patients. Neurological recovery was comparable (mean delta National Institutes of Health Stroke Scale, -2±10 for dominant M2, -5±5 for nondominant M2, and -4±9 [ P=0.24] for M1 occlusions). Furthermore, the effect of reperfusion status on functional outcome was comparable between occlusion divisions (common odds ratio, 1.27; 95% CI, 1.06-1.53 for dominant M2; common odds ratio, 1.32; 95% CI, 0.93-1.87 for nondominant M2; and common odds ratio, 1.35; 95% CI, 1.24-1.46 for M1 occlusions). Conclusions- Outcomes and complication rates after EVT were similar in patients with M2 and M1 occlusions. Although based on observational data and a limited sample size, a similar association of reperfusion status with functional outcome for all subgroups provides no evidence that patients with either a dominant or a nondominant M2 occlusion should be routinely excluded from EVT.
引用
- Compagne KCJ, van der Sluijs PM, van den Wijngaard IR, et al. Endovascular Treatment: The Role of Dominant Caliber M2 Segment Occlusion in Ischemic Stroke. Stroke. 2019. PMID: 31287757. doi:10.1161/STROKEAHA.118.023117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。